665 related articles for article (PubMed ID: 28668871)
21. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes.
Canavese G; Bruzzi P; Catturich A; Vecchio C; Tomei D; Del Mastro L; Carli F; Guenzi M; Lacopo F; Dozin B
Eur J Surg Oncol; 2014 Jul; 40(7):835-42. PubMed ID: 24684810
[TBL] [Abstract][Full Text] [Related]
22. Impact of sentinel node tumor burden on outcome of invasive breast cancer patients.
Meattini I; Desideri I; Saieva C; Francolini G; Scotti V; Bonomo P; Greto D; Mangoni M; Nori J; Orzalesi L; Fambrini M; Bianchi S; Livi L
Eur J Surg Oncol; 2014 Oct; 40(10):1195-202. PubMed ID: 25179162
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
[TBL] [Abstract][Full Text] [Related]
24. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy.
Viale G; Maiorano E; Pruneri G; Mastropasqua MG; Valentini S; Galimberti V; Zurrida S; Maisonneuve P; Paganelli G; Mazzarol G
Ann Surg; 2005 Feb; 241(2):319-25. PubMed ID: 15650643
[TBL] [Abstract][Full Text] [Related]
25. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
[TBL] [Abstract][Full Text] [Related]
26. Axillary treatment of patients with breast cancer and micrometastatic disease in the sentinel lymph node Our experience.
Morlino A; La Torre G; Patitucci G; Cammarota A
Ann Ital Chir; 2017; 88():360-364. PubMed ID: 29051403
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of sentinel lymph node intraoperative examination in 753 women with breast cancer: are we overtreating patients?
Taffurelli M; Montroni I; Santini D; Fiacchi M; Zanotti S; Ugolini G; Serra M; Rosati G
Ann Surg; 2012 May; 255(5):976-80. PubMed ID: 22415419
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of sentinel lymph node biopsy prior to axillary lymph node dissection: the role of isolated tumor cells/micrometastases and multifocality/multicentricity-a retrospective study of 1214 breast cancer patients.
Schröder L; Fricker R; Stein RG; Rink T; Fitz H; Blasius S; Wöckel A; Müller T
Arch Gynecol Obstet; 2018 Jun; 297(6):1509-1515. PubMed ID: 29594495
[TBL] [Abstract][Full Text] [Related]
29. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma.
Viale G; Maiorano E; Mazzarol G; Zurrida S; Galimberti V; Luini A; Renne G; Pruneri G; Maisonneuve P; Veronesi U
Cancer; 2001 Sep; 92(6):1378-84. PubMed ID: 11745213
[TBL] [Abstract][Full Text] [Related]
30. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy.
Langer I; Marti WR; Guller U; Moch H; Harder F; Oertli D; Zuber M
Ann Surg; 2005 Jan; 241(1):152-8. PubMed ID: 15622003
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.
Classe JM; Loaec C; Gimbergues P; Alran S; de Lara CT; Dupre PF; Rouzier R; Faure C; Paillocher N; Chauvet MP; Houvenaeghel G; Gutowski M; De Blay P; Verhaeghe JL; Barranger E; Lefebvre C; Ngo C; Ferron G; Palpacuer C; Campion L
Breast Cancer Res Treat; 2019 Jan; 173(2):343-352. PubMed ID: 30343457
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node biopsy in breast cancer New indications and our experience.
Zanghì G; Rinzirillo NM; Caponnetto AM; Vecchio R; Catania V; Leanza V
Ann Ital Chir; 2015; 86():508-12. PubMed ID: 26898363
[TBL] [Abstract][Full Text] [Related]
33. Predictive factors of isolated tumor cells and micrometastases in axillary lymph nodes in breast cancer.
Madsen EV; Elias SG; van Dalen T; van Oort PM; van Gorp J; Gobardhan PD; Bongers V
Breast; 2013 Oct; 22(5):748-52. PubMed ID: 23313060
[TBL] [Abstract][Full Text] [Related]
34. Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution.
Grabau D; Dihge L; Fernö M; Ingvar C; Rydén L
Eur J Surg Oncol; 2013 Jun; 39(6):601-7. PubMed ID: 23579175
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node.
Rivers AK; Griffith KA; Hunt KK; Degnim AC; Sabel MS; Diehl KM; Cimmino VM; Chang AE; Lucas PC; Newman LA
Ann Surg Oncol; 2006 Jan; 13(1):36-44. PubMed ID: 16378156
[TBL] [Abstract][Full Text] [Related]
36. Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes.
Houvenaeghel G; Boher JM; Reyal F; Cohen M; Garbay JR; Classe JM; Rouzier R; Giard S; Faure C; Charitansky H; Tunon de Lara C; Daraï E; Hudry D; Azuar P; Gimbergues P; Villet R; Sfumato P; Lambaudie E
Eur J Cancer; 2016 Nov; 67():106-118. PubMed ID: 27640137
[TBL] [Abstract][Full Text] [Related]
37. Role of frozen section in sentinel lymph node biopsy for breast cancer in the era of the ACOSOG Z0011 and IBCSG 23-10 trials.
Lombardi A; Nigri G; Maggi S; Stanzani G; Vitale V; Vecchione A; Nania A; Amanti C
Surgeon; 2018 Aug; 16(4):232-236. PubMed ID: 29329752
[TBL] [Abstract][Full Text] [Related]
38. Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy.
Mustać E; Matusan-Ilijas K; Marijić B; Smokvina M; Jonjić N
Int J Surg Pathol; 2010 Feb; 18(1):36-41. PubMed ID: 19448065
[TBL] [Abstract][Full Text] [Related]
39. Primary breast cancer features can predict additional lymph node involvement in patients with sentinel node micrometastases.
Carcoforo P; Maestroni U; Querzoli P; Lanzara S; Maravegias K; Feggi L; Soliani G; Basaglia E
World J Surg; 2006 Sep; 30(9):1653-7. PubMed ID: 16927059
[TBL] [Abstract][Full Text] [Related]
40. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
Goyal A; Newcombe RG; Chhabra A; Mansel RE
Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]